Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
Next Generation Protein Therapeutics and Bioconjugates Summit

Next Generation Protein Therapeutics and Bioconjugates Summit

Categories

Date of beginning

Tuesday, 12 June 2018

Duration

3 days

Deadline for abstracts

Monday, 11 June 2018

City

San Francisco

Country

USA

Contact

Angel Huertas

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Expected participants

0

Participants

0

Memo

The 13th Annual Next Generation Protein Therapeutics and Bioconjugates Summit delivers the very latest results from an ever-expanding number of multifunctional molecules in development and offers you the best opportunity to learn from world-renowned academics and industry visionaries who are expanding the frontiers of biologic drugs.



Hear from the best and the brightest speakers spanning across industry and academia:



FDA Feedback: Regulatory Guidance and Expectations for Next Generation Protein Therapeutics and Bioconjugates

Presented by: Christopher Sheth, Supervisory Pharmacologist, Division of Hematology Oncology Toxicology, FDA



From Antibodies to Synthetic Proteins

Presented by: Sachdev Sidhu, Professor, Donnelly Centre, University of Toronto



Lessons Learned from the Clinical Development of ADCs: Moving Forward

Presented by: Rakesh Dixit, Vice President RandD, Global Head, Biologics Safety

Assessment, MedImmune Inc.



By attending, you will gain valuable knowledge from more than 35 presentations showcasing new, unpublished data, and exclusive case studies to help you:



• Determine what modalities are moving the needle

• Evaluate creative protein engineering and design approaches for non mAb products

• Learn how the next generation of targets will be identified and what challenges are anticipated

• Discover where the future lies for bioconjugates beyond cytotoxins

• Development of next generation conjugation techniques

• Apply new technologies for challenging targets

• Achieve delivery into cells and across the blood-brain barrier

• Gain lessons learnt from translation from discovery to the clinic

• Uncover what the regulatory expectations are for next generation therapeutics and bioconjugates



Time: 7:00 am to 4:20 pm



Prices:

Industry Rate: All Access Pass *Save 400 when you book by April 20th: USD 2699.0,

Industry Rate: Next Generation Protein Therapeutics Summit Pass *Save 400 when you book by April 20th: USD 2299.0,

Academic/Government Rate: All Access Pass: USD 1099.0,

Academic/Government Rate: Next Generation Protein Therapeutics Summit Pass: USD 699.0



Venue Details: Park Central Hotel, 50 Third Street, San Francisco, 94103, United States